A look into…Migraine
Did you know that June, in terms of daylight hours, is the longest month of the year, despite being only 30 days long? Here’s something else you might not know about June, it’s Migraine Awareness Month…
Migraine, derived from the Greek word ‘hemikrania’ meaning pain on one side of the head, is the most common neurological condition affecting nearly 15% of the worldwide population. The prevalence between countries differs; within Europe, the UK shows the highest rate and Spain the lowest.
Like many neurological conditions migraine is complex, with patients exhibiting symptoms on a scale from acute to chronic. This can mean that many cases go undiagnosed. To overcome this, patient populations are classified by either a definite or a probable diagnosis status. Characteristics such as the severity of the headache, frequency per month and the Midas score for probable and definite cases can also be viewed within the database. These populations are then classified further by identifying the laterality and location of the pain; a key consideration for current and future treatment options in development.
Migraine is usually associated with various co-morbid conditions including: angina, stroke and epilepsy. The populations where these conditions are more prominent have been defined. The combination of these aspects has produced over 160 sub-populations for over 5 countries!
Almost 5% of the total incidence of Migraine can be assigned to a patient having had more than 15 Migraines per month. If a patient has more than 15 Migraines per month, they are automatically classified as a ‘definite’ case.